Evidence map›Paper›PMID 29580570›Full record

ArticleBiological psychiatry2018

Increased Alcohol Seeking in Mice Lacking Gpr88 Involves Dysfunctional Mesocorticolimbic Networks.

Sami Ben Hamida, Sueli Mendonça-Netto, Tanzil Mahmud Arefin, Md Taufiq Nasseef, Laura-Joy Boulos, Michael McNicholas, Aliza Toby Ehrlich, Eleanor Clarke, Luc Moquin, Alain Gratton and 4 more

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Biological psychiatry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 58 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Biological psychiatry global open science · 2023
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 5 countries.

Sami Ben HamidaDépartement de Médecine Translationnelle et Neurogénétique, Institut de Génétique et de Biologie Moléculaire et Cellulaire, Institut National de la Santé et de la Recherche Médicale U-964, Centre National de la Recherche Scientifique UMR-7104, University of Strasbourg, Illkirch-Graffenstaden, Strasbourg, France; Douglas Mental Health Institute, Department of Psychiatry, McGill University, Montreal, Quebec, Canada.
Sueli Mendonça-NettoDepartament de Ciencies Experimentals i de la Salut, Universitat Pompeu Fabra, Barcelona, Spain.
Tanzil Mahmud ArefinDepartment of Radiology, Medical Physics, Medical Center University of Freiburg, Faculty of Medicine, Freiburg, Germany; Bernstein Center Freiburg, University of Freiburg, Freiburg, Germany; Bernard and Irene Schwartz Center for Biomedical Imaging, Department of Radiology, New York University School of Medicine, New York, New York.
Md Taufiq NasseefDouglas Mental Health Institute, Department of Psychiatry, McGill University, Montreal, Quebec, Canada.
Laura-Joy BoulosDépartement de Médecine Translationnelle et Neurogénétique, Institut de Génétique et de Biologie Moléculaire et Cellulaire, Institut National de la Santé et de la Recherche Médicale U-964, Centre National de la Recherche Scientifique UMR-7104, University of Strasbourg, Illkirch-Graffenstaden, Strasbourg, France; Douglas Mental Health Institute, Department of Psychiatry, McGill University, Montreal, Quebec, Canada.
Michael McNicholasDouglas Mental Health Institute, Department of Psychiatry, McGill University, Montreal, Quebec, Canada.
Aliza Toby EhrlichDépartement de Médecine Translationnelle et Neurogénétique, Institut de Génétique et de Biologie Moléculaire et Cellulaire, Institut National de la Santé et de la Recherche Médicale U-964, Centre National de la Recherche Scientifique UMR-7104, University of Strasbourg, Illkirch-Graffenstaden, Strasbourg, France; Douglas Mental Health Institute, Department of Psychiatry, McGill University, Montreal, Quebec, Canada.
Eleanor ClarkeDouglas Mental Health Institute, Department of Psychiatry, McGill University, Montreal, Quebec, Canada.
Luc MoquinDouglas Mental Health Institute, Department of Psychiatry, McGill University, Montreal, Quebec, Canada.
Alain GrattonDouglas Mental Health Institute, Department of Psychiatry, McGill University, Montreal, Quebec, Canada.
Emmanuel DarcqDouglas Mental Health Institute, Department of Psychiatry, McGill University, Montreal, Quebec, Canada.
Laura Adela HarsanEngineering Science, Computer Science and Imaging Laboratory, Integrative Multimodal Imaging in Healthcare, University of Strasbourg - Centre National de la Recherche Scientifique, Strasbourg, France; Department of Biophysics and Nuclear Medicine, Faculty of Medicine, University Hospital Strasbourg, Strasbourg, France; Department of Radiology, Medical Physics, Medical Center University of Freiburg, Faculty of Medicine, Freiburg, Germany.
Rafael MaldonadoDepartament de Ciencies Experimentals i de la Salut, Universitat Pompeu Fabra, Barcelona, Spain.
Brigitte Lina KiefferDépartement de Médecine Translationnelle et Neurogénétique, Institut de Génétique et de Biologie Moléculaire et Cellulaire, Institut National de la Santé et de la Recherche Médicale U-964, Centre National de la Recherche Scientifique UMR-7104, University of Strasbourg, Illkirch-Graffenstaden, Strasbourg, France; Douglas Mental Health Institute, Department of Psychiatry, McGill University, Montreal, Quebec, Canada. Electronic address: brigitte.kieffer@douglas.mcgill.ca.
McGill University · CADouglas Mental Health University Institute · CAUniversitat Pompeu Fabra · ESInserm · FRLaboratoire des Sciences de l'Ingénieur, de l'Informatique et de l'Imagerie · FRNew York University · US

Funding

The Role of Striosome Neurons in Mediating Opiod RewardP50DA005010 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI FANSELOW, MICHAEL S · 1987 to 2021
$30.7M
Nr4a1 and GPR88 as novel gene targets for alcoholism: mouse genetic approachesU01AA016658 · NIAAA · UNIVERSITE DE STRASBOURG · PI LAURA ADELA HARSAN · 2006 to 2026
$3.8M
NIAAA NIH HHS U01 AA016658NIDA NIH HHS P50 DA005010
6 · The paper itself

Abstract

backgoundAlcohol use disorder (AUD) is devastating and poorly treated, and innovative targets are actively sought for prevention and treatment. The orphan G protein-coupled receptor GPR88 is enriched in mesocorticolimbic pathways, and Gpr88 knockout mice show hyperactivity and risk-taking behavior, but a potential role for this receptor in drug abuse has not been examined.

methodsWe tested Gpr88 knockout mice for alcohol-drinking and -seeking behaviors. To gain system-level understanding of their alcohol endophenotype, we also analyzed whole-brain functional connectivity in naïve mice using resting-state functional magnetic resonance imaging.

resultsGpr88 knockout mice showed increased voluntary alcohol drinking at both moderate and excessive levels, with intact alcohol sedation and metabolism. Mutant mice also showed increased operant responding and motivation for alcohol, while food and chocolate operant self-administration were unchanged. Alcohol place conditioning and alcohol-induced dopamine release in the nucleus accumbens were decreased, suggesting reduced alcohol reward in mutant mice that may partly explain enhanced alcohol drinking. Seed-based voxelwise functional connectivity analysis revealed significant remodeling of mesocorticolimbic centers, whose hallmark was predominant weakening of prefrontal cortex, ventral tegmental area, and amygdala connectional patterns. Also, effective connectivity from the ventral tegmental area to the nucleus accumbens and amygdala was reduced.

conclusionsGpr88 deletion disrupts executive, reward, and emotional networks in a configuration that reduces alcohol reward and promotes alcohol seeking and drinking. The functional connectivity signature is reminiscent of alterations observed in individuals at risk for AUD. The Gpr88 gene, therefore, may represent a vulnerability/resilience factor for AUD, and a potential drug target for AUD treatment.

Indexed as

Alcohol DrinkingAlcoholismAmygdalaAnimalsBehavior, AnimalBrainDopamineEthanolMagnetic Resonance ImagingMaleMiceMice, KnockoutReceptors, G-Protein-CoupledRewardSelf AdministrationDopamineEthanolGpr88 protein, mouseReceptors, G-Protein-CoupledAmygdalaEthanol voluntary drinkingGpr88 knockout miceOperant self-administrationOrphan G protein–coupled receptorPrefrontal cortexResting-state functional magnetic resonance imagingVentral tegmental area

Identifiers

PMID29580570
PMCPMC6054571
OpenAlexW2793301337

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.